文献速递先天性心脏病外科

心脏位置、形态与手术技术对异位症Fontan长期结局的影响

Impact of cardiac position, morphology and operative technique on long-term Fontan outcomes in heterotaxy†.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

本研究纳入1985至2021年82例接受Fontan手术的异位症患者,与150例三尖瓣闭锁和144例左心发育不良综合征患者比较。右房异构与左房异构20年无移植生存率相当,但右房异构Fontan时肺静脉干预更多。异位症住院死亡率高于三尖瓣闭锁和左心发育不良综合征,但2000年后无早期死亡,20年无移植生存率与左心发育不良综合征相似。

要点

  • 右房异构与左房异构20年无移植生存率相当,但右房异构需更多肺静脉干预。
  • 下腔静脉-对侧肺动脉Fontan生存率100%,下腔静脉-同侧肺动脉心尖位20年生存率67%。
  • 异位症住院死亡率高于三尖瓣闭锁和左心发育不良综合征,但2000年后无早期死亡。

核心结论

  • 多种路由技术可成功克服异位症解剖挑战。
  • 异位症住院死亡率较高,但总体生存与左心发育不良综合征相似。
  • 右房异构与左房异构生存相当,但右房异构Fontan时肺静脉干预更多。

研究设计与样本

  • 回顾性队列研究,纳入1985至2021年82例接受Fontan手术的异位症患者。
  • 对照组为150例三尖瓣闭锁和144例左心发育不良综合征患者。
  • 采用Kaplan-Meier法和Cox比例风险模型分析无移植生存率和结局预测因素。

主要发现

  • 右房异构(n=45)与左房异构(n=37)20年无移植生存率分别为76%(95%CI 57-87%)和68%(95%CI 47-82%),P=0.22。
  • 手术技术包括心外管道66%、心房内管道9%和侧隧道18%。
  • 心脏位置和心尖-腔静脉并置不影响结局。
  • 下腔静脉-对侧肺动脉Fontan生存率100%,下腔静脉-同侧肺动脉心尖位20年生存率67%(95%CI 34-87%)。
  • 异位症住院死亡率9.8%(95%CI 5-19%),高于三尖瓣闭锁1.3%(95%CI 0.3-5.3%,P<0.01)和左心发育不良综合征2.8%(95%CI 1.1-7.3%,P=0.02);2000年后各组无早期死亡。

临床怎么用

  • 异位症Fontan手术可根据解剖挑战选择心外管道、心房内管道或侧隧道等技术。
  • 右房异构患者Fontan时需警惕并准备肺静脉干预。
  • 下腔静脉-同侧肺动脉心尖位路由与较低生存率相关,应优化手术策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to assess the outcomes of heterotaxy patients who underwent the Fontan operation, focusing on morphological features and surgical techniques. METHODS: Eighty-two consecutive heterotaxy patients who underwent the Fontan operation from 1985 to 2021 were compared to 150 patients with tricuspid atresia (TA) and 144 patients with hypoplastic left heart syndrome (HLHS). The Kaplan-Meier method and Cox proportional hazard model were used to analyse transplant-free survival and predictor of outcomes. RESULTS: The 20-year transplant-free survival rates were comparable between right atrial isomerism (RAI, n = 45) and left atrial isomerism (LAI, n = 37) [RAI versus LAI, 76% (95% confidence interval, 57-87%) vs 68% (47-82%), P = 0.22], although more pulmonary vein interventions at Fontan were needed in RAI. Surgical techniques included extracardiac conduit in 66%, intra-atrial conduit in 9% and lateral tunnel in 18% of the cases. Cardiac position and apicocaval juxtaposition did not influence outcomes, but the inferior vena cava (IVC)-contralateral pulmonary artery (PA) Fontan was associated with 100% survival, while the IVC-ipsilateral PA Fontan at the cardiac apex showed a 67% (34-87%) survival rate at 20 years. In-hospital mortality was higher in heterotaxy [9.8% (5-19%)] compared to TA [1.3% (0.3-5.3%), P<0.01) and HLHS [2.8% (1.1-7.3%), P = 0.02], with no early death after 2000 in any group. The 20-year transplant-free survival in heterotaxy [72% (59-82%)] was similar to that in HLHS [80% (69-87%), P = 0.11]. CONCLUSIONS: Various routing techniques can be successfully applied to overcome anatomical challenges in heterotaxy. Despite higher in-hospital mortality, overall survival was similar to HLHS. RAI had comparable survival to LAI with more pulmonary vein interventions at Fontan.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Kadowaki S, Fan CS, Zahiri Y, et al. Impact of cardiac position, morphology and operative technique on long-term Fontan outcomes in heterotaxy†. Eur J Cardiothorac Surg. 2025. PMID: 39878882. doi:10.1093/ejcts/ezaf025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。